Contraception Pipeline Review and Market Updates, H1 2015

Global Markets Direct's, ‘Contraception - Pipeline Review, H1 2015', provides an overview of the Contraception's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Contraception, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Contraception and special features on late-stage and discontinued projects.

Get a copy of this report at . (This is a premium report price at US$2000 for a single user PDF license)

The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.


- The report provides a snapshot of the global therapeutic landscape of Contraception

- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

- The report reviews key players involved in the therapeutics development for Contraception and enlists all their major and minor projects

- The report summarizes all the dormant and discontinued pipeline projects

- A review of the Contraception products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

Table of Contents:

Global Markets Direct Report Coverage 8
Contraception Overview 9
Therapeutics Development 10
Pipeline Products for Contraception - Overview 10
Pipeline Products for Contraception - Comparative Analysis 11
Contraception - Therapeutics under Development by Companies 12
Contraception - Therapeutics under Investigation by Universities/Institutes 14
Contraception - Pipeline Products Glance 15
Late Stage Products 15
Clinical Stage Products 16
Early Stage Products 17
Unknown Stage Products 18
Contraception - Products under Development by Companies 19
Contraception - Products under Investigation by Universities/Institutes 21
Contraception - Companies Involved in Therapeutics Development 22